Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board
25 janv. 2021 06h00 HE
|
Diversigen, Inc.
ST. PAUL, Minn., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ: OSUR), today announced that Eric Pamer, M.D., Professor of Medicine, Section...
Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study
25 juin 2020 08h00 HE
|
Diversigen, Inc.
ST. PAUL, Minn., June 25, 2020 (GLOBE NEWSWIRE) -- Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced...